Russell Alan J

Chief Scientific Officer

1 company

Excellent

Trades Analyzed

12M Win Rate

90.9%

Avg 3M Return

+13.0%

Avg 12M Return

+31.2%

Russell Alan J is a Chief Scientific Officer at Edgewise Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 32 sells.

Estimated insider holdings value: $826K based on current market prices.

Holdings by Company

EWTXNov 12, 2025

Current Shares23.4K

Value$825.7K

Net Activity-827,736

Bought: 0Sold: 827.7K

Showing 10 filings (page 2)

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
May 2, 2023	EWTX Edgewise Therapeutics, Inc.	Chief Scientific Officer	Sale+OE	1,602	$8.90	$14,265.65	-0.9%	-16.7%	+117.3%
Nov 15, 2021	EWTX Edgewise Therapeutics, Inc.	Chief Scientific Officer	Sell	479	$19.11	$9,155.40	-92.6%	-41.5%	-46.5%
Nov 12, 2021	EWTX Edgewise Therapeutics, Inc.	Chief Scientific Officer	Sell	69,740	$19.91	$1,388,787.60	-28.7%	-34.5%	-44.2%
Nov 8, 2021	EWTX Edgewise Therapeutics, Inc.	Chief Scientific Officer	Sell	29,451	$19.82	$583,823.46	-8.1%	-37.7%	-52.2%
Nov 3, 2021	EWTX Edgewise Therapeutics, Inc.	Chief Scientific Officer	Sell	44,172	$17.88	$789,908.90	-7.1%	-28.9%	-47.9%
Oct 15, 2021	EWTX Edgewise Therapeutics, Inc.	Chief Scientific Officer	Sell	7,182	$18.17	$130,482.95	-1.6%	-2.7%	-41.3%
Oct 11, 2021	EWTX Edgewise Therapeutics, Inc.	Chief Scientific Officer	Sell	1,270	$18.02	$22,885.40	-0.8%	+6.5%	-40.6%
Oct 8, 2021	EWTX Edgewise Therapeutics, Inc.	Chief Scientific Officer	Sell	21,028	$18.39	$386,742.62	-4.2%	-0.7%	-45.6%
Oct 5, 2021	EWTX Edgewise Therapeutics, Inc.	Chief Scientific Officer	Sell	5,778	$18.24	$105,409.04	-1.1%	-10.3%	-42.1%
Sep 29, 2021	EWTX Edgewise Therapeutics, Inc.	Chief Scientific Officer	Sell	26,454	$17.10	$452,483.04	-4.6%	-11.8%	-43.5%